IRIS - Res&Arch Institutional Research Information System - Research & Archive

VEDOVATI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.120
AS - Asia 2.613
EU - Europa 2.020
SA - Sud America 566
Continente sconosciuto - Info sul continente non disponibili 246
AF - Africa 74
OC - Oceania 3
Totale 8.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.023
SG - Singapore 1.277
BR - Brasile 444
IT - Italia 418
CN - Cina 387
IE - Irlanda 378
RU - Federazione Russa 367
HK - Hong Kong 314
VN - Vietnam 228
FR - Francia 156
DE - Germania 147
UA - Ucraina 127
SE - Svezia 109
FI - Finlandia 103
GB - Regno Unito 87
BD - Bangladesh 66
IN - India 54
KR - Corea 54
TR - Turchia 41
CA - Canada 40
IQ - Iraq 37
MX - Messico 35
AR - Argentina 29
AT - Austria 26
EC - Ecuador 22
PK - Pakistan 22
PL - Polonia 22
CO - Colombia 20
UZ - Uzbekistan 20
ZA - Sudafrica 15
VE - Venezuela 14
ID - Indonesia 13
JP - Giappone 13
MA - Marocco 13
BE - Belgio 12
ES - Italia 12
PH - Filippine 10
SA - Arabia Saudita 10
TN - Tunisia 10
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
CH - Svizzera 8
LT - Lituania 8
MY - Malesia 8
NL - Olanda 8
PE - Perù 8
PY - Paraguay 8
KE - Kenya 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
JM - Giamaica 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
LB - Libano 5
NP - Nepal 5
OM - Oman 5
UY - Uruguay 5
AO - Angola 4
GR - Grecia 4
IL - Israele 4
BO - Bolivia 3
ET - Etiopia 3
GY - Guiana 3
KW - Kuwait 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
RO - Romania 3
TH - Thailandia 3
AU - Australia 2
BH - Bahrain 2
BY - Bielorussia 2
DK - Danimarca 2
KG - Kirghizistan 2
PR - Porto Rico 2
PT - Portogallo 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
CI - Costa d'Avorio 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KH - Cambogia 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MU - Mauritius 1
Totale 8.389
Salva come PNG Salva come JPEG
Città #
Singapore 899
Dublin 377
Chandler 325
San Jose 315
Hong Kong 312
Ashburn 192
San Mateo 176
Moscow 138
Santa Clara 134
Perugia 128
Boardman 125
Altamura 121
Lauterbourg 98
Ann Arbor 91
Medford 91
Princeton 90
Lawrence 89
Beijing 87
Dong Ket 86
Los Angeles 65
Jacksonville 62
Munich 57
Ho Chi Minh City 55
Seoul 54
New York 48
Wilmington 48
Andover 46
The Dalles 43
São Paulo 42
Redmond 36
Hanoi 34
Des Moines 31
Phoenix 25
Piscataway 24
Turku 23
Nuremberg 22
Helsinki 21
Orem 21
Rio de Janeiro 20
Chennai 19
Redwood City 19
Saint Petersburg 19
Dallas 18
Frankfurt am Main 18
Rome 18
Baghdad 15
Brooklyn 15
Izmir 15
London 15
Montreal 15
Norwalk 14
San Paolo di Civitate 14
Woodbridge 14
Amelia 13
Houston 13
Brussels 12
Tashkent 12
Tokyo 12
Belo Horizonte 11
Columbus 11
Manchester 11
Shanghai 11
Warsaw 11
Boston 10
Brasília 10
Buffalo 10
Stockholm 10
Chicago 9
Lahore 9
Milan 9
Amman 8
Denver 8
Vienna 8
Campinas 7
Curitiba 7
Falkenstein 7
Haiphong 7
Istanbul 7
Johannesburg 7
Mexico City 7
Nairobi 7
Poplar 7
Quito 7
Toronto 7
Atlanta 6
Da Nang 6
Dhaka 6
Guangzhou 6
Hefei 6
Lappeenranta 6
Medellín 6
New Delhi 6
Salvador 6
San Francisco 6
Sorocaba 6
Ankara 5
Basingstoke 5
Bogotá 5
Caracas 5
Chongqing 5
Totale 5.255
Salva come PNG Salva come JPEG
Nome #
The sentinel node biopsy in patients with thick melanoma:outcome analysis from a single-institution database 164
Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis. 149
Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model 143
Aspirin for preventing the recurrence of venous thromboembolism. 137
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 128
Antecolic or Retrocolic Alimentary Limb in Laparoscopic Roux-en-Y Gastric Bypass? A Meta-Analysis 118
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 115
Thrombophilia and cerebral vein thrombosis 112
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 109
A new strategy for anticoagulation: The factor XI inhibitors 108
Acute pulmonary embolism: external validation of the 2014 risk stratification model of the European Society of Cardiology 108
Patients aged 90  years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study 108
Anticoagulation for atrial fibrillation in patients with active cancer: Reply to the ‘Letter to the Editor’ from Dr. Sorigue et al 108
A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. 106
[ANMCO position paper: Use of new oral anticoagulants for the treatment and prevention of pulmonary thromboembolism] 104
Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation 103
Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation 101
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 99
Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study 99
Incidence of venous thromboembolism in patients undergoing laparoscopic surgery for colorectal cancer 98
Carotid plaque detection improves the predictve value of CHA 2 DS 2 -VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 97
[2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism: what's new?] 95
Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation 94
PO-40 - Real-life use of non-vitamin k antagonist oral anticoagulants in patients with cancer associated venous thromboembolism: data from a prospective cohort 93
A Randomized Study on 1-Week Versus 4-Week Prophylaxis for Venous Thromboembolism After Laparoscopic Surgery for Colorectal Cancer Reply 92
Incidence and risk factors for venous thromboembolism after laparoscopic surgery for colorectal cancer 92
Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation 92
Use of non-vitamin K antagonist oral anticoagulants for non-valvular atrial fibrillation in real-life: comparison with phase III trials 90
Beyond the guidelines: Novelties, changes and unsolved issues from the 2019 ESC guidelines on pulmonary embolism 90
Oxygen saturation or respiratory rate to improve risk stratification in hemodynamically stable patients with acute pulmonary embolism 89
Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism 89
Seizures, headache and thrombocytopenia: diagnosis and treatment do not always come in a standard sequence 88
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 88
Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study 88
Accuracy of Physicians in Differentiating Type 1 and Type 2 Myocardial Infarction Based on Clinical Information 88
Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. 87
Combined oral anticoagulants and antiplatelets: benefits and risks. 86
Multidetector CT scan for acute pulmonary embolism: Embolic burden and clinical outcome 86
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 85
Rivaroxaban versus placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer 85
Vitamin K and non-vitamin K antagonists oral anticoagulants for non-valvular atrial fibrillation in real-life 84
Global thromboelastometry in patients receiving direct oral anticoagulants: the RO-DOA study 84
Patients with cancer and atrial fibrillation treated with doacs: A prospective cohort study 83
Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis 83
Intra-abdominal drainage after pancreatic resection: Is it really necessary? A meta-analysis of short-term outcomes 83
Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis 82
Direct oral anticoagulants in patients with VTE and cancer: A systematic review and meta-analysis 81
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation 81
Thrombotic risk after a major bleeding during anticoagulation: A clinical case 80
A randomized study on 1 vs. 4 weeks prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer 78
Fixed-dose rivaroxaban is not associated with increased recurrent venous thromboembolism or major bleeding in patients with a high or low body weight 77
Patients with acute pulmonary embolism at intermediate risk for death: Can we further stratify? 77
Prediction of major bleeding in patients receiving DOACs for venous thromboembolism: A prospective cohort study 76
Venous thromboembolism and cancer: Current and future role of direct-acting oral anticoagulants 76
Reply 75
Efficacy of rivaroxaban for thromboprophylaxis after knee arthroscopy (ERIKA): A phase ii, multicentre, double-blind, placebo-controlled randomised study 74
Clinical prediction models in hospitalized patients with COVID-19: A multicenter cohort study 72
[Pulmonary hypertension associated with left heart diseases: pathophysiology, diagnosis, treatment] 72
Endothelial dysfunction in patients with spontaneous venous thromboembolism. 72
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function. 71
Predictors of new onset atrial fibrillation after myocardial infarction 71
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism 67
Diagnosis of infection by SARS-COV-2: Is one molecular test enough? 66
Risk factors for cerebral ischemic events in patients with atrial fibrillation on warfarin for stroke prevention. 65
Prognostic value of troponins in acutepulmonary embolism: a meta-analysis. 65
One week vs. four week heparin prophylaxis after laparoscopic surgery for colorectal cancer. The pro-laps pilot feasibility study 65
Diagnosis and prognosis of acute pulmonary embolism: focus on serum troponins. 64
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 64
Real-life use of non-vitamin K antagonist oral anticoagulants in comparison with vitamin K antagonists for non-valvular atrial fibrillation: data from a prospective cohort 63
MDCT-detected embolic burden and clinical outcome in patients with acute pulmonary embolism 63
Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 63
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 62
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 62
Sex-specific differences in the presentation, clinical course, and quality of life of patients with acute venous thromboembolism according to baseline risk factors. Insights from the PREFER in VTE 62
Upper extremities deep vein thrombosis treated with oral direct anticoagulants: A prospective cohort study 62
To drain or not to drain extraperitoneal colorectal anastomosis? A systematic review and meta-analysis. 61
To drain or not to drain elective uncomplicated laparoscopic cholecystectomy? A systematic review and meta-analysis 61
Prognostic value of the CHA2DS2Vasc score in patients experiencing a myocardial infarction 61
Old and new oral anticoagulants forvenous thromboembolism and atrial fibrillation: A review of the literature. 60
Multidetectorcomputed tomography for acute pulmonary embolism: diagnosis and riskstratification in a single test. 60
Right ventricle dysfunction in patients with pulmonary embolism. 59
Treatment of venous thromboembolism with rivaroxaban in relation to body weight: A sub-analysis of the EINSTEIN DVT/PE studies 59
[A new anticoagulant strategy: the factor XI inhibitors] 59
Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis 58
Novel oral anticoagulants for patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 57
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. 56
Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis 56
Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management 56
Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. 55
Efficacy and safety of direct oral anticoagulants after pulmonary embolism: A meta-analysis 55
Novel oral anticoagulants in patients with venous thromboembolism and active cancer: a systematic review and meta-analysis 55
Identification of hemodynamically stable patients with acute pulmonary embolism at high risk for death: external validation of different models 54
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 53
Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. 53
Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study 53
Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleeding 53
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 52
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 51
[Anticoagulation therapy during pulmonary embolism follow-up in clinical practice] 50
Management of heavy menstrual bleeding during direct oral anticoagulant therapy for recurrent venous thromboembolism: A case report 50
Totale 8.033
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.541
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.541
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022560 0 0 8 20 32 4 8 206 24 59 91 108
2022/20231.272 94 293 18 71 76 121 0 45 493 5 33 23
2023/2024496 26 54 29 9 6 1 107 3 41 35 104 81
2024/20251.594 18 130 45 89 238 59 76 106 340 103 260 130
2025/20263.269 231 191 181 467 423 253 617 193 329 258 89 37
2026/2027332 81 166 85 0 0 0 0 0 0 0 0 0
Totale 8.642